1. Issued in 2014 – SCAAR

2. SCAAR Annual report 2013

3. Issued in 2014 – SCAAR Working group SCAAR 2013 Chair Stefan James, MD, PhD, Uppsala Deputy chair Bo Lagerqvist, MD, PhD, Uppsala Oskar Angerås, MD, Gothenburg Jörg Carlsson, MD, PhD, Kalmar Agneta Flinck, MD, PhD, Gothenburg Ole Fröbert, MD, PhD, Örebro Matthias Götberg, MD, PhD, Lund Robert Kastberg, MD, Gävle Johan Nilsson, MD, PhD, Umeå Göran Olivecrona, MD, PhD, Lund Elmir Omerovic, MD, PhD, Gothenburg Jonas Persson, MD, PhD, Stockholm Nawzad Saleh, MD, PhD, Stockholm

4. Issued in 2014 – SCAAR Figure 1. Volume trends 1982–2013.

5. Issued in 2014 – SCAAR Figure 2. Number of coronary angiographies per hospital, 2012–2013.

6. Issued in 2014 – SCAAR Figure 3. Number of angiographies per 100 000 inhabitants in the patient’s home county, 2013.

7. Issued in 2014 – SCAAR Figure 4. Number of ischaemic heart disease diagnoses (I20–I25) per 100 000 inhabitants (from National Board of Health and Welfare statistical databases), in the patient’s home county, 2012.

8. Issued in 2014 – SCAAR Figure 5. Change in number of angiographies per 100 000 inhabitants in the patient's home county from 2012 to 2013.

9. Issued in 2014 – SCAAR Table 1. Indication for coronary angiography in detail, number of patients and proportion, 2013.

10. Issued in 2014 – SCAAR Figure 6. Angiographic finding in suspected ischaemic heart disease, per hospital, 2013.

11. Issued in 2014 – SCAAR Figure 7. Number of coronary angiographies per age group, 2000–2013.

12. Issued in 2014 – SCAAR Figure 8. Proportion of coronary angiographies per age group, 2000–2013.

13. Issued in 2014 – SCAAR Figure 9. Histogram of age at procedure, 2013.

14. Issued in 2014 – SCAAR Figure 10. Number of angiographies for STEMI per 100 000 inhabitants in the patient's home county, 2013.

15. Issued in 2014 – SCAAR Figure 11. Change in number of angiographies in STEMI per 100 000 inhabitants in the patient's home county from 2012 to 2013.

16. Issued in 2014 – SCAAR Figure 12. Primary decision following angiography as suggested by the angiographer, 2000–2013.

17. Issued in 2014 – SCAAR Figure 13. Primary decision following angiography as suggested by the angiographer, 2000–2013.

18. Issued in 2014 – SCAAR Figure 14. Primary decision after coronary angiography in STEMI, per age group, all findings, 2013.

19. Issued in 2014 – SCAAR Figure 15. Proportion of patients without angiographically significant stenoses with indication of stable coronary artery disease, unstable angina, NSTEMI, STEMI or unclear chest pain, per gender and age group, 2013 (number of patients above the bar).

20. Issued in 2014 – SCAAR Figure 16. Bypass surgery as primary decision following angiography, as suggested by the angiographer, 2000–2013.

21. Issued in 2014 – SCAAR Figure 17. Primary decision after angiography in patients with three-vessle disease (STEMI excluded), by region, 2013.

22. Issued in 2014 – SCAAR Figure 18. Number of PCI per type and hospital, 2012 and 2013.

23. Issued in 2014 – SCAAR Figure 19. Number of PCIs (all indications) per hospital indicating whether it took place in on-call time or in office hours, 2013.

24. Issued in 2014 – SCAAR Figure 20. Number of ischaemic heart disease diagnoses (I20–I25) per 100 000 inhabitants (from National Board of Health and Welfare statistical databases), in the patient’s home county, 2012.

25. Issued in 2014 – SCAAR Figure 21. Number of PCI per 100 000 inhabitants in the patient's home county, 2013.

26. Issued in 2014 – SCAAR Figure 22. Indication for PCI per year, 2000–2013.

27. Issued in 2014 – SCAAR Figure 23. Risk factors for PCI patients per year, 2000–2013.

28. Issued in 2014 – SCAAR Figure 24. Treated segments, 2013.

29. Issued in 2014 – SCAAR Figure 25. Primary decision in stenosis in left main trunk per year, 2003–2013 (diagnostic PCI, patients with STEMI or previous CABG, and patients where surgery has been declined are excluded).

30. Issued in 2014 – SCAAR Figure 26. Primary decisions after coronary angiography with finding of 3-vessel disease at the different hospitals in patients patients age < 80 with diabetes and stable coronary artery disease, 2006–2013.

31. Issued in 2014 – SCAAR Figure 27. Primary decision in stenosis in left main trunk per hospital with > 10 patients, 2013 (diagnostic PCI, patients with STEMI, previous CABG, and patients where surgery has been declined are excluded).

32. Issued in 2014 – SCAAR Figure 28. Primary decisions after coronary angiography with finding of 3-vessel disease, per hospital in patients age < 80 with diabetes and stable coronary artery disease, 2007–2013.

33. Issued in 2014 – SCAAR Figure 29. Distribution of PCI patients in relation to age and gender, all ages and per age group (number above the bar), 2013.

34. Issued in 2014 – SCAAR Figure 30. Primary decision following angiography in STEMI patients, 2000–2013.

35. Issued in 2014 – SCAAR Figure 31. Primary decision following angiography in STEMI patients, 2000–2013.

36. Issued in 2014 – SCAAR Figure 32. PCI patients with indication of STEMI, 2000–2013.

37. Issued in 2014 – SCAAR Figure 33. Angiographic findings in STEMI patients, 2000–2013.

38. Issued in 2014 – SCAAR Figure 34. One-year mortality after PCI in STEMI patients, 2004–2013 (mean value, 95 % confidence interval).

39. Issued in 2014 – SCAAR Figure 35. Proportion of cardiogenic shock among the PCI-treated STEMI patients, 2000–2013 (diagnostics only excluded).

40. Issued in 2014 – SCAAR Figure 36. Age distribution in STEMI patients, 2000–2013.

41. Issued in 2014 – SCAAR Figure 37. 30-day mortality after PCI in STEMI patients, per age group, 2004–2013 (mean value, 95 % confidence interval).

42. Issued in 2014 – SCAAR Figure 38. 30-day mortality after PCI in STEMI patients, 2004–2013 (mean value, 95 % confidence interval).

43. Issued in 2014 – SCAAR Figure 39. Indication for PCI per hospital, sorted by proportion of STEMI, 2013.

44. Issued in 2014 – SCAAR Figure 40. Primary decisions following angiography in STEMI per region, 2013 (number above the bars).

45. Issued in 2014 – SCAAR Figure 41. Proportion of GP IIb/IIIa inhibitor/bivalirudin before or during PCI in STEMI patients, per preparation and hospital, 2013.

46. Issued in 2014 – SCAAR Figure 42. GP IIb/IIIa inhibitor and bivalirudin before or during PCI, per indication, 2013.

47. Issued in 2014 – SCAAR Figure 43. GP IIb/IIIa inhibitors before or during PCI STEMI, per year.

48. Issued in 2014 – SCAAR Figure 44. Anticoagulation (AC) treatment before or during PCI procedure in STEMI patients, 2005–2013.

49. Issued in 2014 – SCAAR Figure 45. Anticaogulation treatment before or during PCI procedure in stable angina, 2005–2013.

50. Issued in 2014 – SCAAR Figure 46. Anticaogulation treatment before or during PCI procedure in NSTEMI patients, 2005–2013.

51. Issued in 2014 – SCAAR Figure 47. Proportion of PCI patients with stable angina treated with P2Y12 receptor blockers, 2009–2013.

52. Issued in 2014 – SCAAR Figure 48. Proportion of PCI patients with NSTEMI treated with P2Y12 receptor blockers, 2009–2013.

53. Issued in 2014 – SCAAR Figure 49. Proportion of PCI patients with STEMI treated with P2Y12 receptor blockers, 2009–2013.

54. Issued in 2014 – SCAAR Figure 50. Proportion of PCI patients with stable angina treated with P2Y12 receptor blockers, per hospital, 2013.

55. Issued in 2014 – SCAAR Figure 51. Proportion of PCI patients with NSTEMI treated with P2Y12 receptor blockers, per hospital, 2013.

56. Issued in 2014 – SCAAR Figure 52. Proportion of PCI patients with STEMI treated with P2Y12 receptor blockers, per hospital, 2013.

57. Issued in 2014 – SCAAR Figure 53. Interventions, various adjuvant therapies and diagnostics following PCI, 2005–2013.

58. Issued in 2014 – SCAAR Figure 54. Proportion of PCIs in NSTEMI patients with intravascular ultrasound (IVUS) or with intracoronary pressure measurement (FFR), per hospital, 2013.

59. Issued in 2014 – SCAAR Figure 55. Proportion of intracoronary pressure measurment (FFR) in angiographies for stable coronary artery disease, 2013.

60. Issued in 2014 – SCAAR Figure 56. Proportion of coronary angiography in stable coronary artery disease where IPM was used, 2006–2013.

61. Issued in 2014 – SCAAR Figure 57. Proportion of restenoses of all PCI-treated stenoses, 2003–2013.

62. Issued in 2014 – SCAAR Figure 58. Proportion of in-stent restenosis versus proportion of DES for the different hospitals, 2013.

63. Issued in 2014 – SCAAR Figure 59. Proportion DES of all stents at hospitals concerned, 2013.

64. Issued in 2014 – SCAAR Figure 60. Proportion DES of all stents, per year, 2003–2013.

65. Issued in 2014 – SCAAR Figure 61. Proportion DES of all stents in STEMI patients at hospitals concerned, 2013.

66. Issued in 2014 – SCAAR Figure 62. Used DEB in Sweden, Q1 2009–Q1 2013.

67. Issued in 2014 – SCAAR Figure 63. Used DEB, per hospital, 2013.

68. Issued in 2014 – SCAAR Figure 64. Median volume of contrast agent for angiography without simultaneous PCI per hospital, 2013, excluding patients with previous CABG or other scan requiring contrast agent, e.g. LV-angio are excluded.

69. Issued in 2014 – SCAAR Figure 65. Median volume of contrast agent for angiography irrespective of simultaneous PCI per hospital, 2013.

70. Issued in 2014 – SCAAR Figure 66. Median fluoroscopy time in angiography without simultaneous PCI per hospital, 2013 (patients without previous CABG, hospital with > 10 values).

71. Issued in 2014 – SCAAR Figure 67. Median fluoroscopy time in PCI, irrespective of simultaneous angiography per hospital, 2013 (patients without previous CABG, hospital with > 10 values).

72. Issued in 2014 – SCAAR Figure 68. Median radiation dose (μGy2) in angiography without simultaneous PCI, per hospital, 2013 (excluding patients with previous CABG or other scan requiring contrast agent).

73. Issued in 2014 – SCAAR Figure 69. Median radiation dose (μGy 2 ).

74. Issued in 2014 – SCAAR Figure 70. Proportion of bleeds around the puncture site per vascular closure device (> 50 uses) in PCI, 2013. (Number of complications is stated in the bar, with 95 % confidence interval drawn).

75. Issued in 2014 – SCAAR Figure 71. Puncture site in angio/PCI, 2013.

76. Issued in 2014 – SCAAR Figure 72. Proportion of puncture sites in angio/PCI per hospital, sorted according to radial, 2013.

77. Issued in 2014 – SCAAR Figure 73. Proportion of punctures in the arm in angio/PCI, 2003–2013.

78. Issued in 2014 – SCAAR Figure 74. Proportion of punctures in the arm in PCI in STEMI patients, 2003–2013.

79. Issued in 2014 – SCAAR Figure 75. Proportion of complications in PCI reported from lab, 2013 (with 95 % confidence interval, number of complications stated in the bar).

80. Issued in 2014 – SCAAR Figure 76. Proportion of complications in PCI in STEMI reported from lab, 2013 (with 95 % confidence interval, number of complications stated in the bar).

81. Issued in 2014 – SCAAR Figure 77. Proportion of complications in PCI reported from ward, 2013 (with 95 % confidence interval, number of complications stated in the bar).

82. Issued in 2014 – SCAAR Figure 78. Proportion of bleeding complications in PCI, ward, 2013 (with 95 % confidence interval, number of complications stated in the bar).

83. Issued in 2014 – SCAAR Figure 79. Proportion with bleeding complication in isolated angiography and PCI, 2013. (Number of complications is stated in the bar, with 95 % confidence interval drawn).

84. Issued in 2014 – SCAAR Figure 80. Proportion of complications in angio/PCI per age group, 2003–2013 (Number of complications stated in the bar, with 95 % confidence interval drawn).

85. Issued in 2014 – SCAAR Figure 81. Proportion of complications in PCI reported from both lab and ward, 2013 (Number of complications stated in the bar).

86. Issued in 2014 – SCAAR Figure 82. Proportion of patients with any bleeding on ward, in angiography/PCI, per puncture site and year, 2008–2013.

87. Issued in 2014 – SCAAR Figure 83. Proportion and type of bleeding complication in angiography/PCI, per puncture site, 2013.

88. Issued in 2014 – SCAAR Figure 84. Proportion of neurological complications in angio/PCI per puncture site and year, 2003–2013.

89. Issued in 2014 – SCAAR Figure 85. Indications for CT-angiographies, 2013.

90. Issued in 2014 – SCAAR Figure 86. Proportion of patients with suspected coronary artery disease/unclear chest pain without angiographically significant stenoses at time for CT-angiography, per gender and age group, 2013 (number of patients above the bar).

91. Issued in 2014 – SCAAR Figure 87. Findings in CT-angiography, per centre with > 10 patients, 2013.

92. Issued in 2014 – SCAAR Figure 88. The radiation dose in prospective and retrospective ECG triggering in CT-angiography, 2013. Mean with 95 % confidence interval.

93. Issued in 2014 – SCAAR Figure 89. Median radiation dose in CT-angiography per hospital with > 10 reported values, 2013.

94. Issued in 2014 – SCAAR Figure 90. Trend in the median of radiation dose in CT-angiography, 2008–2013.

95. Issued in 2014 – SCAAR Figure 91. Indication in PCI treatment, 2003–2013.

96. Issued in 2014 – SCAAR Figure 92. Primary decision following angiography in different indications, 2013. Indications Other includes: Unclear chest pain, Arrhythmia investigation, Structural heart defect investigation, Mechanical complication following myocardial infarction, Research and development, Heart failure/cardiomyopathy investigation, Suspected complication in Angio/PCI, Aortic aneurysm/dissection, Check prior to or after transplantation, Cardiac arrest, Suspected complication in CABG, Coronary angiography not performable, Other, Cardiac arrest without STEMI.

97. Issued in 2014 – SCAAR Figure 93. 30-day mortality broken down into different indications for PCI-treated patients. Indications Other includes: Unclear chest pain, Arrhythmia investigation, Structural heart defect investigation, Mechanical complication following myocardial infarction, Research and development, Heart failure/cardiomyopathy investigation, Suspected complication in Angio/PCI, Aortic aneurysm/dissection, Check prior to or after transplantation, Cardiac arrest, Suspected complication in CABG, Coronary angiography not performable, Other, Cardiac arrest without STEMI.

98. Issued in 2014 – SCAAR Figure 94. Distribution of waiting time (days from admission to PCI treatment) for NSTEMI patients, 2013.

99. Issued in 2014 – SCAAR Figure 95. Distribution of waiting time (days from admission to PCI treatment) for NSTEMI patients. Broken down between hospitals with > 10 patients, 2013.

100. Issued in 2014 – SCAAR Figure 96. 30-day mortality for PCI-treated NSTEMI patients broken down by time from admission to hospital to day of PCI, 2013.

101. Issued in 2014 – SCAAR Figure 97. Mean age of PCI-treated NSTEMI patients broken down by time from admission to hospital to day of PCI, 2013.

102. Issued in 2014 – SCAAR Figure 98. Trend in 30-day mortality after PCI treatment, 2003–2013.